Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
Researchers from UCL Cancer Center have offered essential molecular insights into how an injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.
A very uncommon but frequently aggressive type of brain tumour called a glioma may be caused by damage, according to key molecular research from the UCL Cancer Centre. Although there may be a connection between head trauma and an increase in brain tumour incidence, the evidence is conflictin
he UCL Cancer Center researchers have offered essential molecular insights of how injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.
Researching the wall separating the circulatory system from the neurological system has been highly difficult or limited in its use of models. In order to properly investigate potential new treatments for brain tumours, researchers have created a more realistic model.
The presence of a brain tumour can be determined by identifying a crucial membrane protein in urine, according to research from Nagoya University in Japan. By eliminating the need for intrusive tests and raising the possibility that tumours are found early enough for surgery, their protein m
Researchers have uncovered a gene that is overexpressed in mutated IDH1. Studies in human cells and a novel mouse model both show that this gene, called ZMYND8, plays a critical role in radiation resistance. When they knocked down the gene, the glioma cells became responsive to radiation tre
According to the findings of a study led by UC San Francisco, the progression of a low-grade, slow-growing brain tumour to a deadly one can be delayed if neurosurgeons remove as much as possible soon after diagnosis.
According to research published in the journal 'Nature Communications', highly active cells were found in a tumour which showed how they grow and attack normal tissues of the body.